The ‘right’ timing for durvalumab after chemoradiation in stage III non-small cell lung cancer
@article{ACTR9914, author = {Taysser Sowley and Pilar Garrido}, title = {The ‘right’ timing for durvalumab after chemoradiation in stage III non-small cell lung cancer}, journal = {AME Clinical Trials Review}, volume = {2}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/9914} }